DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mestinon (Pyridostigmine Bromide) - Published Studies


Mestinon Related Published Studies

Well-designed clinical trials related to Mestinon (Pyridostigmine)

Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. [2010.11]

Acetylcholine-esterase inhibitor pyridostigmine decreases T cell overactivation in patients infected by HIV. [2009.08]

Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study. [2009.07]

The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. [2009.03]

A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia. [2008.02]

Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes. [2007.07]

A combination of 6 months of treatment with pyridostigmine and triweekly exercise fails to improve insulin-like growth factor-I levels in fibromyalgia, despite improvement in the acute growth hormone response to exercise. [2007.05]

Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety. [2006.10]

Pyridostigmine treatment trial in neurogenic orthostatic hypotension. [2006.04]

Early and late reversal of rocuronium with pyridostigmine during sevoflurane anaesthesia in children. [2004.10]

Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia. [2004.10]

Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement. [2003.12]

The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis. [2003.10]

Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. [2003.09]

Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure. [2003.08]

Cardiac function during mental stress: cholinergic modulation with pyridostigmine in healthy subjects. [2003.08]

Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study. [2002.07]

Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease. [2002.06]

Side effects of low-dose pyridostigmine bromide are not related to cholinesterase inhibition. [2001.12]

Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine. [2001.04]

Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects. [2001.02]

Reduction of QTc interval dispersion. Potential mechanism of cardiac protection of pyridostigmine bromide. [2000.09]

The effect of oral pyridostigmine bromide nerve agent prophylaxis on return of twitch height in persons receiving succinylcholine. [2000.04]

A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. [1999.10.12]

Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans. [1999.05]

Pyridostigmine cotreatment for controlled ovarian hyperstimulation in low responders undergoing in vitro fertilization-embryo transfer. [1999.04]

Cholinergic stimulation with pyridostigmine, hemodynamic and echocardiographic analysis in healthy subjects. [1999.03]

Cholinergic stimulation with pyridostigmine blunts the cardiac responses to mental stress. [1999.02]

The effect of short-term cortisol changes on growth hormone responses to the pyridostigmine-growth-hormone-releasing-hormone test in healthy adults and patients with suspected growth hormone deficiency. [1998.08]

Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans. [1998.03]

Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects. [1997.12]

Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man. [1997.10]

Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release. [1997.10]

Lack of bioavailability of mebeverine even after pretreatment with pyridostigmine. [1997]

Resting and reflex heart rate responses during cholinergic stimulation with pyridostigmine in humans. [1996.11]

Well-designed clinical trials possibly related to Mestinon (Pyridostigmine)

A systematic review of the pharmacological management of orthostatic hypotension. [2013]

Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure. [2009.03]

A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome. [2009.03]

Terbutaline in myasthenia gravis: A pilot study. [2009.02.15]

[Thymopentin 5 in treatment of relapse after extended thymectomy: a randomized comparative clinical trial of 135 patients with myasthenia gravis] [2008.08.26]

Intestinal gas and bloating: effect of prokinetic stimulation. [2008.08]

[Electroacupuncture warming therapy combined with western medicine for treatment of myasthenia gravis and effect on IL-4 level in the patients] [2007.12]

Palliative care pharmacotherapy literature summaries and analyses. [2007]

Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome. [2005.10]

Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. [2005.05.31]

The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans. [2004.09]

Acetylcholine regulates ghrelin secretion in humans. [2004.05]

Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis. [2002.07]

Cholinergic modulation of growth hormone responses to growth hormone-releasing hormone in uraemic patients on peritoneal dialysis. [2000.11]

Dopaminergic and cholinergic involvement in the inhibitory effect of dexamethasone on the TSH response to TRH. [2000.03]

Quantitative growth hormone secretion and final adult height. [1999.11]

Influence of endogenous cholinergic tone and growth hormone-releasing peptide-6 on exercise induced growth hormone release. [1997.02]

Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man. [1997.01]

Other research related to Mestinon (Pyridostigmine)

[Bioequivalence of pyridostigmine bromide dispersible tablets in rabbits]. [2011.10]

Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. [2010.12]

Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial. [2010.11]

Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. [2010.07.01]

Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy. [2010.06]

The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. [2010.06]

Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness. [2010.03]

Acute electrophysiologic consequences of pyridostigmine inhibition of cholinesterase in humans. [2010.02]

Prolonged cardioprotective effect of pyridostigmine encapsulated in liposomes. [2010.01.02]

Relief from episodic weakness with pyridostigmine in paramyotonia congenita: a family study. [2010.01]

Serum of patients with oral pemphigus vulgaris impairs keratinocyte wound repair in vitro: a time-lapse study on the efficacy of methylprednisolone and pyridostigmine bromide. [2009.10]

Retrospective population pharmacokinetic/pharmacodynamic analysis of pyridostigmine, a cholinesterase inhibitor, in Chinese males. [2009.09]

Effect of pyridostigmine (Mestinon) on human platelet aggregation. [2009.06]

Repeated stress in combination with pyridostigmine Part I: long-term behavioural consequences. [2009.02.11]

The Effect of Oral Buspirone, Pyridostigmine, and Bethanechol on Esophageal Function Evaluated With Combined Multichannel Esophageal Impedance-manometry in Healthy Volunteers. [2008.11.03]

Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. [2008.08]

Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy. [2008.03]

Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis. [2008.02]

Protective effect of reversible cholinesterase inhibitors (tacrine, pyridostigmine) and eqbuche against VX poisoning and brain acetylcholinesterase inhibition in rats. [2008]

Formulation design of an HPMC-based sustained release tablet for pyridostigmine bromide as a highly hygroscopic model drug and its in vivo/in vitro dissolution properties. [2007.11]

Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy. [2007.09]

[Pyridostigmine in the treatment of primary orthostatic hypotension] [2007.05]

Effects of combined exposure to pyridostigmine bromide and shaker stress on acoustic startle response, pre-pulse inhibition and open field behavior in mice. [2007.05]

Factors associated with insensitivity to pyridostigmine therapy in Thai patients with ocular myasthenia gravis. [2007.03]

Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine. [2007.03]

Pyridostigmine in the treatment of orthostatic intolerance. [2007.02]

Other possibly related research studies

An atypical course of myasthenia gravis. [2007]

Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: Next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase. [2008.05.03]

Extended transsternal thymectomy for myasthenia gravis: a report of 19 consecutive cases. [2008.01]

[Lambert-Eaton Myasthenic Syndrome associated with vocal cord carcinoma] [2008.01]

Long-term outcome and quality of life after open and thoracoscopic thymectomy for myasthenia gravis: analysis of 131 patients. [2008.02.23]

Fiberoptic endoscopic evaluation of swallowing with simultaneous Tensilon application in diagnosis and therapy of myasthenia gravis. [2008.02]

[Development of a myasthenia crisis during interferon treatment for chronic C hepatitis] [2007.12]

Myasthenia gravis crisis. [2008.01]

Long-term outcomes of pediatric ocular myasthenia gravis. [2008.07]

Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis. [2008.03]

When the patient fails to respond to treatment: myasthenia gravis. [2007.11]

Myasthenia gravis and thymectomy: an anaesthetic approach. [2007]

Brugada syndrome in the presence of coronary artery disease and parasympathomimetic drug therapy. [2007.08]

Latency and exposure-health associations in Gulf War veterans with early fatigue onsets: a case-control study. [2007.10]

Dropped head sign as the only symptom of myasthenia gravis. [2007]

Post-varicella myasthenia gravis. [2007.06]

Concurrence of non-myasthenic symptoms with myasthenia gravis. [2007.04]

Dropped head as an unusual presenting sign of myasthenia gravis. [2007.04]

Myasthenia gravis: an unrecognized cause of head drop in Parkinson's disease. [2008]

Myasthenia gravis in ectopic thymoma presenting as pleural masses. [2007.07]

Nerve agents. [2007.01]

Myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient. [2007.07]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017